BioHealth Innovation
If you are having trouble viewing this email, please click here

August 7, 2018

Quality Biological, Inc. (QBI) President and CEO Angela Graham joins Rich Bendis for New Episode of BioTalk

Angela Graham, President and CEO of Quality Biological, Inc. (QBI), joins BioTalk host Rich Bendis to discuss growing a business in the Life Sciences Community, her involvement in the BHCR, and recruiting top talent in this region. Angela Graham, President and CEO of Quality Biological, Inc. (QBI), joins BioTalk host Rich Bendis to discuss growing a business in the Life Sciences Community, her involvement in the BHCR, and recruiting top talent in this region.

Angela has been in this industry for decades working for Bristol-Myers Squibb, Pfizer and UCB Pharma before taking over QBI. Her background and expertise is ideally suited to lead the company’s diversification from a leading government contractor into one which also supports the diverse R&D needs of the biopharmaceutical space.

Google Play, iTunes, TuneIn and on the website.

Read More

Cardin Announces Several Small Business Priorities in National Defense Bill | U.S. Senator Ben Cardin of Maryland

U.S. Senator Ben Cardin (D-Md.), Ranking Member of the U.S. Senate Committee on Small Business & Entrepreneurship, today announced several provisions in the 2019 National Defense Authorization Act (NDAA) specifically focused on supporting small businesses in Maryland and nationwide. The annual defense funding bill passed the Senate Wednesday.

Read More

United Therapeutics Corp. gets FDA approval for implantable pump for Remodulin - Washington Business Journal

United Therapeutics Corp. said it has received Food and Drug Administration approval for an implantable pump for Remodulin, its flagship pulmonary arterial hypertension drug.

Read More

QIAGEN and Hamilton Launch New Collaboration to Improve Pre-Analytical Sample Processing for QuantiFERON-TB Gold Plus | Business Wire

QIAGEN N.V. and Hamilton Robotics, a privately held leader in automation and liquid handling technology, today announced a new collaboration to improve processing of QIAGEN’s QuantiFERON-TB Gold Plus (QFT-Plus) diagnostic test through the integration of Hamilton’s Microlab® STAR™ automated liquid handling workstation into the QFT-Plus assay workflow. QIAGEN’s fourth-generation QuantiFERON-TB Gold Plus is the modern gold standard for latent tuberculosis (TB) detection.

Read More

Huge Discount for BioHealth Clients and Partners to Next Month’s RESI Conference, 9/6, Boston

Meet RESI’s Network of Global Investors and Channel Partners

This fall, the Redefining Early Stage Investments Conference (RESI) will expand to include tech hubs and companies rom the First Coast: DC, MD, PA, NJ, NY, RI, CT, and MA. RESI invites earliest stage companies from the discovery stage through venture stage: companies seeking grants, seed, angel, series A, and series B funding.

As a client/partner of BioHealth Innovation and/or an early stage biohealth start-up in the BioHealth Capital Region, you can attend the RESI Boston September Conference at a reduced rate - $300 each ticket for the first 5 signups; each ticket valued at $1,295. 

RESI is a partnering vehicle for you to connect with global investors and strategic partners. You'll have an opportunity to showcase your technology and assets in a poster board format with our table in the exhibit hall. You can participate in partnering and networking all day, and explore the exhibit hall, investor panels and entrepreneur workshops.

Email BioHealth Innovation for the Discount Code and Register Now  

Max:  5 tickets at $300 per tech hub; first come, first served

$300 for Tech Hub Members Includes:

  • 1 Tech Hub Member (BioHealth Innovation Client / Partner) Ticket
  • Present Your Technology in a Poster Board Format at BHI Table
  • Company Datasheet Featured on Website and Newsletter
  • All Day Access to Partnering, Networking, Panels and Workshops
  • Continental Breakfast, Lunch, and Cocktail Reception
  • All Registered Attendees Eligible to Apply to First Coast Innovation Challenge
    • Top 5 companies of the First Coast tech hub members will present their technology as a 10-minute pitch to a panel of early-stage investors.
    • Top 5 will be featured in Marketing Channels
    • It's FREE to Apply


Read More

Joint Economic Committee Holds Hearing on Innovation Economy, Barriers to Accessing Capital -

On the morning of Wednesday, July 25th, the U.S. Congress Joint Economic Committee held a hearing titled The Innovation Economy, Entrepreneurship, and Barriers to Capital Access. The day’s discussion focused on various federal policies that could be pursued by Congress to increase avenues for financing innovative businesses and improve the ranking of the United States as an innovative economy.

Read More

SBIR Office Hours 8/8 and 8/15 for BioHealth Start-ups

Is your biohealth company located in Maryland, DC or Virginia? Are you thinking of applying for a biohealth related SBIR grant?   Does your technology qualify?  Are you eligible?  Should you apply to NIH? NSF? to other organizations?  

Sign up now to learn more from one of BHI’s SBIR consultants. Office hours are scheduled next in Montgomery County August 8th and 15th.  (There is no fee for this service.  Depending upon your technology and stage in the business cycle, BHI may also prepay for experts to help you improve your SBIR and other non-dilutive funding applications. For more information, click here.)

Read More

Office Space Available for BioHealth Start-ups – Montgomery County

Due to company graduations,  co-working and individual office space is becoming available at the Montgomery County innovation centers located in Rockville and Germantown.  Each location offers shared meeting and kitchenette/lunch room space, and affordable, flexible lease terms.  Tenants in these facilities also have access to BHI Entrepreneurs-in-Residence analysts, and other professional staff for additional support. For more information, contact BHI.

Read More

PGDx test gets 'Breakthrough Device' designation - Baltimore

Baltimore-based Personal Genome Diagnostics (PGDx) recently received a designation from federal regulators that’s designed to help allow patients to get quicker access to new devices.

Read More

Landos Biopharma Initiates Phase 1 Clinical Trial of BT-11, an Oral LANCL2 Agonist for Treatment of | Nutritional Immunology and Molecular Medicine Laboratory

Landos Biopharma, Inc., a clinical-stage biopharmaceutical company focused on developing improved treatments for autoimmune diseases, announced today that the first healthy subjects have been dosed in a Phase 1 clinical study of BT-11, a first-in-class, orally-administered, molecule targeting the LANCL2 pathway. The Phase 1 study is a randomized, double-blind, placebo-controlled, single and multiple ascending dose study intended to enroll up to 70 healthy volunteers to evaluate the safety and tolerability of BT-11. BT-11 is in development for treatment of inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD).

Read More

Research Parks: Cutting Edge Now Means ‘Really Robust Amenities’ | Site Selection Magazine

Close proximity to a host research university — check. Sustainably designed and preferably LEED-certified buildings — check. A state-of-the-art telecom infrastructure — check. An office of commercialization — check. These used to define a cutting-edge and competitive research park. Not anymore. Today's "A list" parks, or districts, look more like towns, complete with transit, lodging, residential and retail. Besides those, the University of Maryland's Discovery District in College Park will soon have coworking space, thanks to a recent partnership among the university, global coworking provider WeWork and Chesapeake Realty Partners.

Read More

Foundation for the NIH Selects 3 Finalists for the Inaugural Trailblazer Prize for Clinician-Scientists

The Foundation for the National Institutes of Health (FNIH) has selected three finalists of the inaugural Trailblazer Prize for Clinician-Scientists (Trailblazer Prize): Daniel Bauer, M.D., Ph.D., Harvard Medical School, Jaehyuk Choi, M.D., Ph.D., Feinberg School of Medicine, Northwestern University and Michael Fox, M.D., Ph.D., Beth Israel Deaconess Medical Center, Harvard Medical School. These three early-career clinician-scientists, whose work spans the fields of hematology, oncodermatology and neurology/psychiatry, are being recognized for their outstanding research contributions that have the potential to or have led to innovations in patient care. The winner will be announced and awarded the Trailblazer Prize and a $10,000 honorarium at the FNIH Annual Fall Board Dinner on Wednesday, October 24, 2018 in Washington, D.C.

Read More

Top 50 Angel Investors Based On Investment Volume And Successful Exits

Who are the leading angel investors startup entrepreneurs should be pitching right now? How do you connect with them?

Effective fundraising for startups isn’t about how many people and firms you can blast your opportunity out to. It’s about getting in front of the right investors, with a strong pitch deck. A recent DocSend survey shows successfully funded startups contacted an average of just 58 investors, made 40 meetings, and took just 12.5 weeks to close their funding round.

Read More

Funding Opportunity: BARDA DRIVe EZ-BAA

As a BARDA DRIVe Accelerator, the Center for Biotechnology is pleased to announce that the simplified funding application process, called EZ BAA, is now open. Medical product developers, research teams, and companies offering disruptive solutions to health security threats are invited to submit abstracts using this simplified EZ BAA process.

Applications accepted through this streamlined process must offer transformative innovation, products and technologies to protect Americans from health security threats. This application process is a business friendly simple abstract.

In-scope priority areas include products and solutions to reduce illness and death from sepsis as part of DRIVe’s Solving Sepsis initiative; technologies and processes to identify infections and exposures to biological and other health threats, as outlined in the Early Notification to Act, Control, and Treat (ENACT) initiative; and tools and techniques to mitigate the damages and loss of life associated with catastrophic events.

Read More


Thursday, Septmember 27, 20184:00-7:00 PM

Enjoy an evening with food, fun and lively conversation at Biotech and Beer. Meet old friends and new colleagues in the life science community. Complimentary admission for any bioscience company employees, and university students and researchers with advanced registration. All others may purchase tickets.

Read More

Technology advocate Congressman Gerry Connolly talks about digital health and innovation with Vibrent Health - Vibrent Health

Fairfax health technology company Vibrent Health hosted Congressman Gerry Connolly (D-VA, 11th District) at the company’s new offices for a town hall style meeting today, to talk about digital health initiatives, health care access, immigration issues and other topics of interest to Vibrent’s 140 employees.

“Congressman Connolly understands the importance of integrating health data from various sources to promote the best outcomes for individuals and for public health,” said Vibrent Health Founder and CEO Praduman “PJ” Jain. “We are eager to work with our leaders in government to continue developing digital health technology that advances health research and empowers people to live healthier lives.”

Read More

Trump’s pick to head White House science office gets good reviews - AAAS

The long wait for a White House science adviser is over. President Donald Trump announced today that he intends to nominate meteorologist Kelvin Droegemeier, a university administrator and former vice-chair of the governing board of the U.S. National Science Foundation (NSF), to be director of the White House Office of Science and Technology Policy (OSTP). The OSTP director traditionally, but not always, also holds the title of the president’s science adviser.

Read More

VT Corporate Research Center

VIP MEDIA DAY is an opportunity for local, regional and national media outlets to get a first-ever exclusive look into the Virginia Tech Corporate Research Center (VTCRC), located in Blacksburg, VA, and adjacent to Virginia Tech.

Read More

UEDA Selects Finalists for 2018 Awards of Excellence - University Economic Development Association

The 2018 UEDA Awards of Excellence finalists have been chosen following an extremely close competition this year. Higher education institutions and organizations across North America submit nominations annually for innovative programs that focus on developing economic prosperity in their communities and beyond. A panel of university and economic development professionals have chosen 24 finalists from the group of nominated projects.

Read More

Home | About BHI | BHI News | Programs | Partners | Contact

Copyright © BioHealth Innovation 2017
All Rights Reserved.